157 related articles for article (PubMed ID: 36748180)
1. Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy.
Claps F; van de Kamp MW; Mayr R; Bostrom PJ; Shariat SF; Hippe K; Bertz S; Neuzillet Y; Sanders J; Otto W; van der Heijden MS; Jewett MAS; Stöhr R; Zlotta AR; Trombetta C; Eckstein M; Mertens LS; Burger M; Soorojebally Y; Wullich B; Bartoletti R; Radvanyi F; Pavan N; Sirab N; Mir MC; Pouessel D; van der Kwast TH; Hartmann A; Lotan Y; Bussani R; Allory Y; van Rhijn BWG
BJU Int; 2023 Aug; 132(2):170-180. PubMed ID: 36748180
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy.
Lonati C; Baumeister P; Ornaghi PI; Di Trapani E; De Cobelli O; Rink M; Karnes RJ; Poyet C; Simone G; Afferi L; Necchi A; Briganti A; Montorsi F; Krajewski W; Antonelli A; Cerruto MA; Zamboni S; Simeone C; Mordasini L; Mattei A; Moschini M;
Eur Urol Focus; 2022 Mar; 8(2):457-464. PubMed ID: 33867307
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy.
Li Q; Assel M; Benfante NE; Pietzak EJ; Herr HW; Donat M; Cha EK; Donahue TF; Bochner BH; Dalbagni G
Eur Urol Focus; 2019 Jan; 5(1):104-108. PubMed ID: 28753857
[TBL] [Abstract][Full Text] [Related]
4. Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies.
Necchi A; Raggi D; Gallina A; Madison R; Colecchia M; Lucianò R; Montironi R; Giannatempo P; Farè E; Pederzoli F; Bandini M; Bianchi M; Colombo R; Gandaglia G; Fossati N; Marandino L; Capitanio U; Dehò F; Ali SM; Chung JH; Ross JS; Salonia A; Briganti A; Montorsi F
Eur Urol; 2020 Apr; 77(4):439-446. PubMed ID: 31708296
[TBL] [Abstract][Full Text] [Related]
5. Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients.
Moschini M; Shariat SF; Lucianò R; D'Andrea D; Foerster B; Abufaraj M; Bandini M; Dell'Oglio P; Damiano R; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A
Clin Genitourin Cancer; 2017 Aug; 15(4):e603-e607. PubMed ID: 28040422
[TBL] [Abstract][Full Text] [Related]
6. Variant histologies of urothelial carcinoma: Does it change the survival outcomes in patients managed with radical cystectomy?
Pereira JN; Reis JD; Braga I; Freitas R; Moreira da Silva V; Magalhães S; Lobo F; Morais A
Arch Ital Urol Androl; 2022 Jun; 94(2):138-143. PubMed ID: 35775335
[TBL] [Abstract][Full Text] [Related]
7. What Is the Significance of Variant Histology in Urothelial Carcinoma?
Lobo N; Shariat SF; Guo CC; Fernandez MI; Kassouf W; Choudhury A; Gao J; Williams SB; Galsky MD; Taylor JA; Roupret M; Kamat AM
Eur Urol Focus; 2020 Jul; 6(4):653-663. PubMed ID: 31530497
[TBL] [Abstract][Full Text] [Related]
8. Impact of variant histology on upstaging and survival in patients with nonmuscle invasive bladder cancer undergoing radical cystectomy.
McFadden J; Tachibana I; Adra N; Collins K; Cary C; Koch M; Kaimakliotis H; Masterson TA; Rice KR
Urol Oncol; 2024 Mar; 42(3):69.e11-69.e16. PubMed ID: 38267301
[TBL] [Abstract][Full Text] [Related]
9. Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy?
Cimadamore A; Lonati C; Di Trapani E; De Cobelli O; Rink M; Zamboni S; Simeone C; Soria F; Briganti A; Montorsi F; Afferi L; Mattei A; Carando R; Ornaghi PI; Tafuri A; Antonelli A; Karnes RJ; Colomer A; Sanchez-Salas R; Contieri R; Hurle R; Poyet C; Simone G; D'Andrea D; Shariat SF; Galfano A; Umari P; Francavilla S; Roumiguie M; Terrone C; Hendricksen K; Krajewski W; Buisan O; Laukhtina E; Xylinas E; Alvarez-Maestro M; Rouprêt M; Montironi R; Moschini M;
Urol Oncol; 2022 Jun; 40(6):273.e11-273.e20. PubMed ID: 35216892
[TBL] [Abstract][Full Text] [Related]
10. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M
Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387
[TBL] [Abstract][Full Text] [Related]
11. Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder.
Abufaraj M; Shariat SF; Foerster B; Pozo C; Moschini M; D'Andrea D; Mathieu R; Susani M; Czech AK; Karakiewicz PI; Seebacher V
World J Urol; 2018 Feb; 36(2):231-240. PubMed ID: 29127452
[TBL] [Abstract][Full Text] [Related]
12. Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm?
Kaimakliotis HZ; Monn MF; Cary KC; Pedrosa JA; Rice K; Masterson TA; Gardner TA; Hahn NM; Foster RS; Bihrle R; Cheng L; Koch MO
Urol Oncol; 2014 Aug; 32(6):833-8. PubMed ID: 24954925
[TBL] [Abstract][Full Text] [Related]
13. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
Xylinas E; Rink M; Robinson BD; Lotan Y; Babjuk M; Brisuda A; Green DA; Kluth LA; Pycha A; Fradet Y; Faison T; Lee RK; Karakiewicz PI; Zerbib M; Scherr DS; Shariat SF
Eur J Cancer; 2013 May; 49(8):1889-97. PubMed ID: 23466126
[TBL] [Abstract][Full Text] [Related]
14. The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy.
Marks P; Gild P; Soave A; Janisch F; Minner S; Engel O; Vetterlein MW; Shariat SF; Sauter G; Dahlem R; Fisch M; Rink M
Surg Oncol; 2019 Mar; 28():208-213. PubMed ID: 30851902
[TBL] [Abstract][Full Text] [Related]
15. The impact of histological reclassification during pathology re-review--evidence of a Will Rogers effect in bladder cancer?
Linder BJ; Boorjian SA; Cheville JC; Sukov WR; Thapa P; Tarrell RF; Frank I
J Urol; 2013 Nov; 190(5):1692-6. PubMed ID: 23707452
[TBL] [Abstract][Full Text] [Related]
16. Molecular Subtyping of Clinically Localized Urothelial Carcinoma Reveals Lower Rates of Pathological Upstaging at Radical Cystectomy Among Luminal Tumors.
Lotan Y; Boorjian SA; Zhang J; Bivalacqua TJ; Porten SP; Wheeler T; Lerner SP; Hutchinson R; Francis F; Davicioni E; Svatek RS; Chen CL; Black PC; Gibb EA
Eur Urol; 2019 Aug; 76(2):200-206. PubMed ID: 31092337
[TBL] [Abstract][Full Text] [Related]
17. Impact of Variant Histology on Occult Nodal Metastasis after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Review of the National Cancer Database.
Fu M; Klose C; Sparks A; Whalen M
Clin Genitourin Cancer; 2022 Apr; 20(2):e135-e139. PubMed ID: 34961704
[TBL] [Abstract][Full Text] [Related]
18. Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy.
Martini A; Afferi L; Zamboni S; Schultz JG; Lonati C; Mattei A; Karnes RJ; Soligo M; Stabile A; Di Trapani E; De Cobelli O; Simone G; Simeone C; Alvarez-Maestro M; Gandaglia G; Gallina A; Colombo R; Briganti A; Montorsi F; Xylinas E; Shariat SF; Moschini M
J Urol; 2021 Oct; 206(4):885-893. PubMed ID: 34032498
[TBL] [Abstract][Full Text] [Related]
19. Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy.
Soave A; Riethdorf S; Dahlem R; Minner S; Weisbach L; Engel O; Fisch M; Pantel K; Rink M
BJU Int; 2017 Jun; 119(6):854-861. PubMed ID: 28182321
[TBL] [Abstract][Full Text] [Related]
20. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
Kim SP; Frank I; Cheville JC; Thompson RH; Weight CJ; Thapa P; Boorjian SA
J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
